Dis-Chem Pharmacies Overview
- Founded
-
1992

- Status
-
Public
- Employees
-
20,071

- Stock Symbol
-
DCP

- Investments
-
6
- Share Price
-
$1.19
- (As of Monday Closing)
Dis-Chem Pharmacies General Information
Description
Dis-Chem Pharmacies Ltd is a pharmaceutical company based in South Africa. Its product portfolio includes personal care products, beauty products, healthcare and nutrition products, and dispensary and baby care products. The operating segments of the group are Retail and Wholesale. It derives maximum revenue from the Retail segment, which includes company stores, retailers of pharmaceutical and a variety of health and beauty products, as well as pharma-logistic services and oncology and retailers of pharmaceutical products. The Wholesale segment consists of the CJ wholesale and company distribution businesses, wholesalers of pharmaceuticals, and a variety of health and beauty products. Geographically, the group carries its business operations principally in South Africa.
Contact Information
- Private Bag X21
- Northriding, 2162
- South Africa
Dis-Chem Pharmacies Stock Performance
(As of Monday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$1.19 | $1.21 | $1.11 - $2.33 | $1.07B | 860M | 1.19M | $0.08 |
Dis-Chem Pharmacies Financials Summary
In Thousands, USD |
TTM 31-Aug-2022 | FY 2022 28-Feb-2022 | FY 2021 28-Feb-2021 | FY 2020 29-Feb-2020 |
---|---|---|---|---|
EV | 2,045,520 | 2,162,383 | 1,495,949 | 1,447,997 |
Revenue | 2,036,337 | 2,042,958 | 1,589,334 | 1,643,118 |
EBITDA | 114,575 | 160,929 | 119,367 | 124,983 |
Net Income | 66,571 | 57,341 | 40,443 | 40,983 |
Total Assets | 883,446 | 912,251 | 876,922 | 683,008 |
Total Debt | 275,593 | 292,147 | 297,622 | 238,654 |
Dis-Chem Pharmacies Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Dis-Chem Pharmacies Executive Team (3)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Ivan Saltzman | Chief Executive Officer & Founder | ||
Rui Morais | Chief Financial Officer & Board Member | ||
Lynette Saltzman | Co-Founder |
Dis-Chem Pharmacies Board Members (3)
Name | Representing | Role | Since |
---|---|---|---|
00000000 0000000 | Self | Board Member | 000 0000 |
0000 000000 | Self | Board Member | 000 0000 |
000 000000 | Dis-Chem Pharmacies | Chief Financial Officer & Board Member | 000 0000 |
Dis-Chem Pharmacies Signals
Dis-Chem Pharmacies Investments & Acquisitions (6)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
0000 0000 | 01-Mar-2022 | 0000000000 | 00.000 | Internet Retail | 000 00000 |
00000 0000000 | 01-Nov-2021 | 000000000 | 000.00 | Insurance Brokers | |
00000000 0000 | 01-Oct-2021 | 0000000000 | 000.00 | Pharmaceuticals | |
00000000000 | 01-Mar-2021 | 0000000000 | 00.000 | Clinics/Outpatient Services | |
Baby City | 01-Jan-2021 | Merger/Acquisition | 000.00 | Clothing | 0000 0000 |
Dis-Chem Pharmacies Subsidiaries (3)
Company Name | Industry | Location | Founded |
---|---|---|---|
HealthForce | Acquirer | Rosebank, South Africa | 2018 |
0000 0000 | Internet Retail | Kempton Park, South Africa | 0000 |
0000 0000 | Clothing | Durban, South Africa | 0000 |
Dis-Chem Pharmacies ESG
Risk Overview
Risk Rating
Updated April, 13, 2023
23.99 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
00.00
Management
Management is related to actions taken to manage ESG issues
00.00
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
00 of 15,233
Rank
Percentile

Food Retailers
Industry
00 of 190
Rank
Percentile

Drug Retail
Subindustry
00 of 29
Rank
Percentile
